Interesting facts
Interesting Facts about O5-ethyl O3-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
This fascinating compound, a member of the dihydropyridine class, showcases the intricate beauty of organic chemistry. Here are some intriguing aspects:
- Pharmacological Potential: Dihydropyridines are renowned for their biological activities, particularly in the field of cardiovascular medicine. This compound may exhibit properties that could lead to the development of new medications aimed at treating hypertension and angina.
- Nitrophenyl Group: The presence of a nitrophenyl group in its structure often signifies interesting electronic properties. This moiety can play a crucial role in various chemical reactions and may influence the compound's reactivity and stability.
- Multi-functional Nature: The existence of multiple carboxylate groups in its structure highlights the compound's versatility. This could pave the way for applications in drug design, agrochemicals, or even materials science.
- Structure-Activity Relationship (SAR): Studying the substitution patterns of this compound could offer insights into how variations affect its biological activity, thus assisting researchers in optimizing therapeutic agents.
In conclusion, O5-ethyl O3-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate is not just a complex organic molecule; it embodies the intersection of synthetic chemistry and potential biomedical applications, inspiring scientists to explore its full capabilities.
Synonyms
nitrendipine
39562-70-4
Bayotensin
Baypress
Nidrel
Deiten
Nitrendipinum
Nitrendipin
Nitrendipino
Nitrepin
Bay-e-5009
Bylotensin
BAY e 5009
3-ethyl 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
Nitrendipinum [INN-Latin]
Nitrendipino [INN-Spanish]
Baypress (TN)
CHEBI:7582
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester
EINECS 254-513-1
MFCD00082255
NSC-758466
BRN 0498823
DTXSID0023373
Nitrendipine [USAN:INN:BAN:JAN]
NITRENDIPINE [MI]
NITRENDIPINE [INN]
NITRENDIPINE [JAN]
9B627AW319
NITRENDIPINE [USAN]
NITRENDIPINE [MART.]
ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
NITRENDIPINE [WHO-DD]
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, ethyl methyl ester
MLS000069349
DTXCID203373
NITRENDIPINE [EP IMPURITY]
NITRENDIPINE [EP MONOGRAPH]
5-O-ethyl 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
Ethyl 1,4-dihydro-5-(acetoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-3-pyridincarboxylat
NSC 758466
NCGC00015713-07
SMR000058366
Nitrendipinum (INN-Latin)
Nitrendipino (INN-Spanish)
NITRENDIPINE (MART.)
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-ethyl 5-methyl ester
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, ethyl methyl ester, (+/-)-
Baylotensin
NITRENDIPINE (EP IMPURITY)
NITRENDIPINE (EP MONOGRAPH)
O3-ethyl O5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
SR-01000075334
nitrendipina
UNII-9B627AW319
Nitrendipine,(S)
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester;Nitrendipine;Bayotensin
CAS-39562-70-4
Spectrum_001901
Nitrendipine (Standard)
Opera_ID_928
SpecPlus_000742
Prestwick0_000916
Prestwick1_000916
Prestwick2_000916
Prestwick3_000916
Spectrum2_001565
Spectrum3_000968
Spectrum4_001088
Spectrum5_001655
N-144
(.+/-.)-Nitrendipine
(+-)-Ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate
CBiol_001834
Lopac0_000881
Oprea1_472855
Oprea1_703261
SCHEMBL38972
BSPBio_000792
BSPBio_001399
BSPBio_002575
KBioGR_000119
KBioGR_001476
KBioSS_000119
KBioSS_002432
MLS000759400
MLS001148149
MLS001424133
MLS002153303
MLS002154060
(+/-)-NITRENDIPINE
DivK1c_006838
Nitrendipine, >95%, powder
SPECTRUM1503609
SPBio_001470
SPBio_002981
BPBio1_000872
GTPL2334
CHEMBL3195219
HY-B0424R
KBio1_001782
KBio2_000119
KBio2_002426
KBio2_002687
KBio2_004994
KBio2_005255
KBio2_007562
KBio3_000237
KBio3_000238
KBio3_001795
BRD6392
C08CA08
Nitrendipine (JP18/USAN/INN)
Bio1_000120
Bio1_000609
Bio1_001098
Bio2_000119
Bio2_000599
HMS1361F21
HMS1570H14
HMS1791F21
HMS1989F21
HMS2051B04
HMS2089H15
HMS2093G17
HMS2097H14
HMS2230F04
HMS3262B04
HMS3266B03
HMS3371J07
HMS3393B04
HMS3402F21
HMS3411I14
HMS3651F05
HMS3675I14
HMS3714H14
HMS3884H21
Pharmakon1600-01503609
BCP07540
BRD-6392
HY-B0424
MSK10230
Nitrendipine for peak identification
Tox21_110201
Tox21_500881
AC-648
BBL028163
BDBM50237611
CA-212
CCG-39343
NSC758466
STK368903
AKOS000622913
AKOS015894921
AKOS016340326
Tox21_110201_1
CCG-100991
DB01054
IM57947
KS-1305
LP00881
NC00241
SDCCGSBI-0050856.P004
IDI1_033869
NCGC00015713-04
NCGC00015713-05
NCGC00015713-06
NCGC00015713-08
NCGC00015713-09
NCGC00015713-10
NCGC00015713-11
NCGC00015713-13
NCGC00015713-26
NCGC00024013-02
NCGC00024676-02
NCGC00024676-03
NCGC00024676-04
NCGC00024676-05
NCGC00024676-06
NCGC00024676-07
NCGC00261566-01
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, ethyl methyl ester, (+-)-
IM175687
PD003069
PD033036
SY058769
(+/-)-BAY-E-5009
SBI-0050856.P003
Nitrendipine 100 microg/mL in Acetonitrile
AB00513962
EU-0100881
N1186
NS00007571
S2491
SW219737-1
A10804
C07713
D00629
AB00053154-03
AB00053154_04
AB00053154_05
EN300-18434855
Q416584
SR-01000075334-1
SR-01000075334-2
SR-01000075334-4
SR-01000075334-6
BRD-A02006392-001-06-5
BRD-A02006392-001-09-9
BRD-A02006392-001-15-6
BRD-A02006392-001-16-4
BRD-A02006392-001-17-2
Z239859926
Nitrendipine, European Pharmacopoeia (EP) Reference Standard
(.+/-.)-Ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate
(RS)-Methyl ethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinecarboxylic acid ethyl methyl ester
3-Ethyl 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate #
3-ethyl5-methyl2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
Ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate
methylethyl2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
Nitrendipine for peak identification, European Pharmacopoeia (EP) Reference Standard
(+/-)-ETHYL METHYL 1,4-DIHYDRO-2,6-DIMETHYL-4-(M-NITROPHENYL)-3,5-PYRIDINEDICARBOXYLATE
(RS)-Methyl ethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate - EP Grade
254-513-1
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, ethyl methyl ester, (.+/-.)-
Solubility of O5-ethyl O3-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
Understanding the solubility of the compound C17H18N2O6 reveals several interesting characteristics:
In conclusion, while exact solubility may require empirical testing, predictions suggest that it will be more soluble in polar solvents than in non-polar mediums. Understanding these solubility traits can be crucial for its practical applications and formulation in various chemical processes.